Works matching Cyclin-dependent kinase inhibitors

Results: 4670

USE OF CYCLIN-DEPENDENT KINASE 4 AND 6 INHIBITORS IN TREATING METASTATIC BREAST CANCER - A YEAR-LONG EXPERIENCE OF SUBOTICA GENERAL HOSPITAL IN PATIENT FOLLOW-UP.

Published in:

Medical Review / Medicinski Pregled, 2024, v. 77, n. 3/4, p. 94, doi. 10.2298/MPNS2404094B

By:

ZELEN, Teodora BRDAR;
JOVIŠEVIĆ, Marija;
PRICA, Anja

Publication type:

Article

Phase 2 trial of the cyclin-dependent kinase 4/6 inhibitor palbociclib in patients with retinoblastoma protein-expressing germ cell tumors.

Published in:

Cancer (0008543X), 2015, v. 121, n. 9, p. 1463, doi. 10.1002/cncr.29213

By:

Vaughn, David J.;
Hwang, Wei‐Ting;
Lal, Priti;
Rosen, Mark A.;
Gallagher, Maryann;
O'Dwyer, Peter J.

Publication type:

Article

SKUAMÖZ HÜCRELİ LARİNKS KANSERİNDE p53 MUTASYONU VE p21 SİKLİN BAĞIMLI KİNAZ İNHİBİTÖRÜ EKSPRESYONUNUN SAĞKAUM VE PROGNOSTİK FAKTÖRLERLE İLİŞKİSİ.

Published in:

Nobel Medicus Journal, 2014, v. 10, n. 1, p. 68

By:

Salman, Nergis;
Akın, İstemihan;
Hücümenoğlu, Sema

Publication type:

Article

MYC Upregulation Confers Resistance to Everolimus and Establishes Vulnerability to Cyclin-Dependent Kinase Inhibitors in Pancreatic Neuroendocrine Neoplasm Cells.

Published in:

Neuroendocrinology, 2021, v. 111, n. 8, p. 739, doi. 10.1159/000509865

By:

Terracciano, Francesca;
Capone, Alessia;
Montori, Andrea;
Rinzivillo, Maria;
Partelli, Stefano;
Panzuto, Francesco;
Pilozzi, Emanuela;
Arcidiacono, Paolo Giorgio;
Sette, Claudio;
Capurso, Gabriele

Publication type:

Article

Decreased mitochondrial transcription factor A and mitochondrial DNA copy number promote cyclin-dependent kinase inhibitor 1A expression and reduce tumorigenic properties of colorectal cancer cells.

Published in:

Discover Oncology, 2024, v. 15, n. 1, p. 1, doi. 10.1007/s12672-024-01538-4

By:

Buchwaldt, Jessika;
Fritsch, Tania;
Hartmann, Monika;
Witzel, Hagen Roland;
Kloth, Michael;
Roth, Wilfried;
Tagscherer, Katrin E.;
Hartmann, Nils

Publication type:

Article

Sodium valproate affects the expression of p16INK4a and p21WAFI/Cip1 cyclin‑dependent kinase inhibitors in HeLa cells.

Published in:

Oncology Letters, 2024, v. 28, n. 3, p. N.PAG, doi. 10.3892/ol.2024.14563

By:

Rocha, Marina Amorim;
Cardoso, Adauto Lima;
Martins, Cesar;
Mello, Maria Luiza S.

Publication type:

Article

Recommendations for cyclin‑dependent kinase 4/6 inhibitor treatments in the context of co‑morbidity and drug interactions (Review).

Published in:

Oncology Letters, 2024, v. 27, n. 4, p. N.PAG, doi. 10.3892/ol.2024.14278

By:

Teomete, Mehmet;
Cabuk, Devrim;
Korkmaz, Taner;
Seber, Selcuk;
Ozturk, Ozge Fulya;
Aver, Birkan;
Karaalp, Atila;
Basaran, Gul

Publication type:

Article

MicroRNA-93-5p increases multidrug resistance in human colorectal carcinoma cells by downregulating cyclin dependent kinase inhibitor 1A gene expression.

Published in:

Oncology Letters, 2017, v. 13, n. 2, p. 722, doi. 10.3892/ol.2016.5463

By:

SHI-JUN WANG;
YUN-FEI CAO;
ZU-QING YANG;
ZHI-YUAN JIANG;
BIN CAI;
JIAO GUO;
SEN ZHANG;
XIAO-LONG ZHANG;
FENG GAO

Publication type:

Article

Cyclin-dependent kinase inhibitor 2B gene is associated with the sensitivity of hepatoma cells to Sorafenib.

Published in:

OncoTargets & Therapy, 2019, v. 12, p. 5025, doi. 10.2147/OTT.S196607

By:

Weng, Xie;
Zeng, Lixian;
Yan, Feifei;
He, Mengxue;
Wu, Xiuqiong;
Zheng, Dayong

Publication type:

Article

Potentiation of in vitro and in vivo antitumor efficacy of doxorubicin by cyclin-dependent kinase inhibitor P276-00 in human non-small cell lung cancer cells.

Published in:

BMC Cancer, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1471-2407-13-29

By:

Rathos, Maggie J;
Khanwalkar, Harshal;
Joshi, Kavita;
Manohar, Sonal M;
Joshi, Kalpana S

Publication type:

Article

Hypoxia Promotes Vascular Smooth Muscle Cell Proliferation through microRNA-Mediated Suppression of Cyclin-Dependent Kinase Inhibitors.

Published in:

Cells (2073-4409), 2019, v. 8, n. 8, p. 802, doi. 10.3390/cells8080802

By:

Lee, Jihui;
Kang, Hara

Publication type:

Article

Cyclin-dependent kinase 4 and 6 inhibitors in combination with neoadjuvant endocrine therapy in estrogen receptor-positive early breast cancer: a systematic review and meta-analysis.

Published in:

Clinical & Experimental Medicine, 2023, v. 23, n. 2, p. 245, doi. 10.1007/s10238-022-00814-3

By:

Guan, Yumei;
Shen, Guoshuang;
Fang, Qianqian;
Xin, Yuanfang;
Huo, Xingfa;
Li, Jinming;
Zhao, Fuxing;
Ren, Dengfeng;
Liu, Zhen;
Li, Zitao;
Zhao, Jiuda

Publication type:

Article

Tailoring advanced breast cancer treatment after cyclin-dependent kinase 4/6 inhibitors progression - real-world data analysis.

Published in:

Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1408664

By:

Kubeczko, Marcin;
Polakiewicz-Gilowska, Anna;
Świderska, Katarzyna;
Leśniak, Aleksandra;
Mianowska-Malec, Marta;
Łanoszka, Barbarba;
Chomik, Konstanty;
Grandys, Barbara;
Lisovska, Natalya;
Bobek-Billewicz, Barbara;
Chmielik, Ewa;
Jarząb, Michał

Publication type:

Article

Interactions of cyclin-dependent kinase inhibitors AT-7519, flavopiridol and SNS-032 with ABCB1, ABCG2 and ABCC1 transporters and their potential to overcome multidrug resistance in vitro.

Published in:

Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 1, p. 105, doi. 10.1007/s00280-015-2772-1

By:

Cihalova, Daniela;
Staud, Frantisek;
Ceckova, Martina

Publication type:

Article

Cyclin-Dependent Kinase Inhibitor p21WAF1/CIP1 Facilitates the Development of Cardiac Hypertrophy.

Published in:

Cellular Physiology & Biochemistry (Karger AG), 2017, v. 42, n. 4, p. 1645, doi. 10.1159/000479407

By:

Tong, Yang-Fei;
Wang, Yan;
Ding, Yuan-Yuan;
Li, Jing-Mei;
Pan, Xi-Chun;
Lu, Xiao-Lan;
Chen, Xiao-Hong;
Liu, Ya;
Zhang, Hai-Gang

Publication type:

Article

Anti-cancer therapy with cyclin-dependent kinase inhibitors: impact and challenges.

Published in:

Expert Reviews in Molecular Medicine, 2021, v. 23, p. 1, doi. 10.1017/erm.2021.3

By:

Reinius, Marika A. V.;
Smyth, Elizabeth

Publication type:

Article

Neoadjuvant Therapy of Cyclin-Dependent Kinase 4/6 Inhibitors Combined with Endocrine Therapy in HR+/HER2− Breast Cancer: A Systematic Review and Meta-Analysis.

Published in:

Oncology Research & Treatment, 2021, v. 44, n. 10, p. 557, doi. 10.1159/000518573

By:

Hong, Kai;
Yao, Lingli;
Sheng, Xianneng;
Ye, Dan;
Guo, Yu

Publication type:

Article

Pharmacokinetics and biodistribution of the cyclin-dependent kinase inhibitor -CR8- in mice.

Published in:

BMC Pharmacology & Toxicology, 2013, v. 14, n. 1, p. 1, doi. 10.1186/2050-6511-14-50

By:

Sallam, Hatem;
El-Serafi, Ibrahim;
Meijer, Laurent;
Hassan, Moustapha

Publication type:

Article

Gene polymorphisms of cyclin‐dependent kinase inhibitor and matrix metalloproteinase‐9 in Sudanese patients with esophageal squamous cell carcinoma.

Published in:

Molecular Genetics & Genomic Medicine, 2022, v. 10, n. 12, p. 1, doi. 10.1002/mgg3.2074

By:

Eltayeb, Majdolin Mohammed;
Ali, Mohamed M.;
Omar, Saeed M.;
Mohamed, Nouh Saad;
Adam, Ishag;
Hamdan, Hamdan Z.

Publication type:

Article

A current and comprehensive review of cyclin-dependent kinase inhibitors for the treatment of metastatic breast cancer.

Published in:

2017

By:

Bilgin, Burak;
Sendur, Mehmet A.N.;
Şener Dede, Didem;
Akıncı, Muhammed Bülent;
Yalçın, Bülent;
Şener Dede, Didem;
Akıncı, Muhammed Bülent;
Yalçın, Bülent

Publication type:

journal article

Cyclin-Dependent Kinase Inhibitor 2A is a Key Regulator of Cell Cycle Arrest and Senescence in Endothelial Colony-Forming Cells in Moyamoya Disease.

Published in:

Journal of Korean Neurosurgical Society, 2023, v. 66, n. 6, p. 662, doi. 10.3340/jkns.2023.0005

By:

Seung Ah Choi;
Youn Joo Moon;
Eun Jung Koh;
Ji Hoon Phi;
Ji Yeoun Lee;
Kyung Hyun Kim;
Seung-Ki Kim

Publication type:

Article

Dose and drug changes in chronic lymphocytic leukemia cell response in vitro: A comparison of standard therapy regimens with two novel cyclin-dependent kinase inhibitors.

Published in:

Molecular Medicine Reports, 2019, v. 19, n. 5, p. 3593

By:

Kubczak, Małgorzata;
Szustka, Aleksandra;
Błoński, Jerzy Z.;
Gucký, Tomaš;
Misiewicz, Małgorzata;
Krystof, Vladmir;
Robak, Paweł;
Rogalińska, Małgorzata

Publication type:

Article

Silencing cyclin-dependent kinase inhibitor 3 inhibits the migration of breast cancer cell lines.

Published in:

Molecular Medicine Reports, 2016, v. 14, n. 2, p. 1523, doi. 10.3892/mmr.2016.5401

By:

MIAO DENG;
JIANGUANG WANG;
YANBIN CHEN;
LIKE ZHANG;
GANGQIANG XIE;
QIPENG LIU;
TING ZHANG;
PENGFEI YUAN;
DECHUN LIU

Publication type:

Article

Cyclin-Dependent Kinase 4/6 Inhibitors Plus Endocrine Therapy versus Endocrine Therapy Alone for HR-Positive, HER-2-Negative Early Breast Cancer: Meta-Analysis of Phase III Randomized Clinical Trials.

Published in:

Journal of Personalized Medicine, 2024, v. 14, n. 5, p. 464, doi. 10.3390/jpm14050464

By:

Moraes, Francisco Cezar Aquino de;
de Oliveira Almeida, Gustavo;
Alves, Vinícius Freire Costa;
Priantti, Jonathan N.;
Gomes, Giovanna da Conceição;
Carnevalli, Sarah Vitória Bristot;
Madeira, Thiago;
Vilbert, Maysa;
Stecca, Carlos;
Figueroa Magalhães, Maria Cristina;
Fernandes, Marianne Rodrigues;
dos Santos, Ney Pereira Carneiro

Publication type:

Article

Locoregional Radiotherapy in Patients with Advanced Breast Cancer Treated with Cyclin-Dependent Kinase 4/6 Inhibitors Based on Real-World Data.

Published in:

Pharmaceuticals (14248247), 2024, v. 17, n. 7, p. 927, doi. 10.3390/ph17070927

By:

Kubeczko, Marcin;
Gabryś, Dorota;
Polakiewicz-Gilowska, Anna;
Bobek-Billewicz, Barbara;
Jarząb, Michał

Publication type:

Article

Arthralgia induced by endocrine therapy with or without cyclin‐dependent kinase 4/6 inhibitors in breast cancer: A systematic review and meta‐analysis.

Published in:

Asia Pacific Journal of Clinical Oncology, 2023, v. 19, n. 5, p. e175, doi. 10.1111/ajco.13840

By:

Takatsuka, Daiki;
Sawaki, Masataka;
Hattori, Masaya;
Yoshimura, Akiyo;
Kotani, Haruru;
Kataoka, Ayumi;
Horisawa, Nanae;
Ozaki, Yuri;
Endo, Yuka;
Nozawa, Kazuki;
Iwata, Hiroji

Publication type:

Article

RAZLIKA IZMEĐU NUSPOJAVA INHIBITORA O CIKLINIMA OVISNIH KINAZA 4/6: ISKUSTVA I PREPORUKE ZA SVAKODNEVNU KLINIČKU PRAKSU.

Published in:

Lijecnicki Vjesnik, 2024, v. 146, p. 37, doi. 10.26800/LV-146-supl4-2

By:

Košić, Alojzije;
Skočilić, Iva;
Petrc, Ana-Marija Bukovica;
Kolak, Maja;
Kolovrat, Doris;
Ropac, Sanja;
Marušić, Jasna;
Ferari, Ani Mihaljević;
Dobrila-Dintinjana, Renata;
Golčić, Marin;
Mikolašević, Ivana

Publication type:

Article

Knockdown of Cyclin-Dependent Kinase Inhibitor 3 Inhibits Proliferation and Invasion in Human Gastric Cancer Cells.

Published in:

Oncology Research, 2017, v. 25, n. 5, p. 721, doi. 10.3727/096504016X14772375848616

By:

Yan Li;
Shan Ji;
Li-Ye Fu;
Tao Jiang;
Di Wu;
Fan-Dong Meng

Publication type:

Article

Inhibitors of Cyclin-Dependent Kinases: Types and Their Mechanism of Action.

Published in:

International Journal of Molecular Sciences, 2021, v. 22, n. 6, p. 2806, doi. 10.3390/ijms22062806

By:

Łukasik, Paweł;
Baranowska-Bosiacka, Irena;
Kulczycka, Katarzyna;
Gutowska, Izabela;
Giordano, Antonio

Publication type:

Article

Cyclin-Dependent Kinase Inhibitors KRP1 and KRP2 Are Involved in Grain Filling and Seed Germination in Rice (Oryza sativa L.).

Published in:

International Journal of Molecular Sciences, 2020, v. 21, n. 1, p. 245, doi. 10.3390/ijms21010245

By:

Ajadi, Abolore Adijat;
Tong, Xiaohong;
Wang, Huimei;
Zhao, Juan;
Tang, Liqun;
Li, Zhiyong;
Liu, Xixi;
Shu, Yazhou;
Li, Shufan;
Wang, Shuang;
Liu, Wanning;
Tajo, Sani Muhammad;
Zhang, Jian;
Wang, Yifeng

Publication type:

Article

Cyclin-dependent kinase 4/6 inhibitors combined with stereotactic ablative radiotherapy in oligometastatic HR-positive/HER2-negative breast cancer patients.

Published in:

British Journal of Radiology, 2024, v. 97, n. 1162, p. 1627, doi. 10.1093/bjr/tqae138

By:

Kubeczko, Marcin;
Gabryś, Dorota;
Krzywon, Aleksandra;
Jarząb, Michał

Publication type:

Article

Role of the Combination of Cyclin-Dependent Kinase Inhibitors (CDKI) and Radiotherapy (RT) in the Treatment of Metastatic Breast Cancer (MBC): Advantages and Risks in Clinical Practice.

Published in:

Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.643155

By:

Gagliano, Ambrogio;
Prestifilippo, Angela;
Cantale, Ornella;
Ferini, Gianluca;
Fisichella, Giacomo;
Fontana, Paolo;
Sciacca, Dorotea;
Giuffrida, Dario

Publication type:

Article

Antitumoral effects of cyclin-dependent kinases inhibitors CR8 and MR4 on chronic myeloid leukemia cell lines.

Published in:

Journal of Biomedical Science, 2015, v. 22, n. 1, p. 1, doi. 10.1186/s12929-015-0163-x

By:

Troadec, Samuel;
Blairvacq, Mélina;
Oumata, Nassima;
Galons, Hervé;
Meijer, Laurent;
Berthou, Christian

Publication type:

Article

Cyclin-Dependent Kinase Inhibitors for the Treatment of Breast Cancer: Past, Present, and Future.

Published in:

Pharmacotherapy, 2016, v. 36, n. 6, p. 652, doi. 10.1002/phar.1756

By:

DiPippo, Adam J.;
Patel, Neelam K.;
Barnett, Chad M.

Publication type:

Article

Cyclin-Dependent Kinase 4/6 Inhibitors Combined with Radiotherapy in Curative Breast Cancer Patients Induced Pneumonitis: A Case Report.

Published in:

Life (2075-1729), 2025, v. 15, n. 5, p. 709, doi. 10.3390/life15050709

By:

Hou, Pei-Yu

Publication type:

Article

Evaluation of Cyclin-Dependent Kinase Inhibitor 2A and Hepatocyte Nuclear Factor-1A Gene Polymorphisms in Coronary Artery Diseases.

Published in:

Zagazig University Medical Journal, 2024, v. 30, n. 3, p. 859, doi. 10.21608/ZUMJ.2022.161460.2636

By:

Ibrahimm, Magdy;
Sherif, Abdelsalam;
Mohamed, Dina Salah;
Samy, Walaa

Publication type:

Article

Metal complexes with heteroscorpionate ligand founded on the pyridinamine group: cyclin-dependent kinase 2 inhibitor antimicrobial, antioxidant, and in vitro cytotoxicity, notional studies.

Published in:

International Journal of Pharmaceutical Research (09752366), 2021, v. 13, n. 1, p. 3349, doi. 10.31838/ijpr/2021.13.01.427

By:

MOHAMMED, AESHAH MUHANA;
AL-SHEMARY, REHAB KADHEM RAHEM

Publication type:

Article

IZBOR LIJEČENJA NAKON PROGRESIJE NA TERAPIJU INHIBITORIMA O CIKLINIMA OVISNIH KINAZA 4/6.

Published in:

Lijecnicki Vjesnik, 2024, v. 146, p. 36, doi. 10.26800/LV-146-supl4-2

By:

Salopek, Tihana;
Skočilić, Iva;
Petrc, Ana-Marija Bukovica;
Kolak, Maja;
Kolovrat, Doris;
Ropac, Sanja;
Marušić, Jasna;
Ferari, Ani Mihaljević;
Dobrila-Dintinjana, Renata;
Golčić, Marin;
Mikolašević, Ivana

Publication type:

Article

Role of Cyclin-Dependent Kinase Inhibitors in Endometrial Cancer.

Published in:

International Journal of Molecular Sciences, 2019, v. 20, n. 9, p. 2353, doi. 10.3390/ijms20092353

By:

Giannone, Gaia;
Tuninetti, Valentina;
Ghisoni, Eleonora;
Genta, Sofia;
Scotto, Giulia;
Mittica, Gloria;
Valabrega, Giorgio

Publication type:

Article

Cyclin-dependent kinase inhibitors in malignant hematopoiesis.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.916682

By:

Schirripa, Alessia;
Sexl, Veronika;
Kollmann, Karoline

Publication type:

Article

Selective Cyclin-Dependent Kinase 4/6 Inhibitors as Anticancer Drugs: Moving beyond Hormone Receptor-Positive Breast Cancer.

Published in:

Indian Journal of Medical & Paediatric Oncology, 2019, v. 40, n. 1, p. 15, doi. 10.4103/ijmpo.ijmpo_87_18

By:

Chaudhuri, Tamojit;
Babu, K. Govind;
Lakshmaiah, K. C.;
Dasappa, Lokanatha;
Jacob, Linu Abraham;
Babu, M. C. Suresh;
Rudresha, A. H.;
Lokesh, K. N.;
Rajeev, L. K.

Publication type:

Article

Induction of Eosinophil Apoptosis by the Cyclin- Dependent Kinase Inhibitor AT7519 Promotes the Resolution of Eosinophil-Dominant Allergic Inflammation.

Published in:

PLoS ONE, 2011, v. 6, n. 9, p. 1, doi. 10.1371/journal.pone.0025683

By:

Alessandri, Ana L.;
Duffin, Rodger;
Leitch, Andrew E.;
Lucas, Christopher D.;
Sheldrake, Tara A.;
Dorward, David A.;
Hirani, Nik;
Pinho, Vanessa;
Sousa, Lirlândia Pires de;
Teixeira, Mauro M.;
Lyons, John F.;
Haslett, Christopher;
Rossi, Adriano G.

Publication type:

Article

The driving power of the cell cycle: cyclin-dependent kinases, cyclins and their inhibitors.

Published in:

Bratislava Medical Journal / Bratislavské Lekárske Listy, 2023, v. 124, n. 4, p. 261, doi. 10.4149/BLL_2023_039

By:

HIVES, Mark;
JURECEKOVA, Jana;
HIVES HOLECKOVA, Klaudia;
KLIMENT, Jan;
KMETOVA SIVONOVA, Monika

Publication type:

Article

Dual Suppression of the Cyclin-Dependent Kinase Inhibitors CDKN2C and CDKN1A in Human Melanoma.

Published in:

JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 21, p. 1673, doi. 10.1093/jnci/djs373

By:

Jalili, Ahmad;
Wagner, Christine;
Pashenkov, Mikhail;
Pathria, Gaurav;
Mertz, Kirsten D.;
Widlund, Hans R.;
Lupien, Mathieu;
Brunet, Jean- Philippe;
Golub, Todd R.;
Stingl, Georg;
Fisher, David E.;
Ramaswamy, Sridhar;
Wagner, Stephan N.

Publication type:

Article

The role of FDG PET assessment in patients with advanced breast cancer treated with cyclin-dependent kinase 4/6 inhibitors in the second-line setting.

Published in:

Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1454844

By:

Kubeczko, Marcin;
Polakiewicz-Gilowska, Anna;
D'Amico, Andrea;
Chrabański, Olgierd;
Świderska, Katarzyna;
Chmielik, Ewa;
Blamek, Sławomir;
Handkiewicz-Junak, Daria;
Jarząb, Michał

Publication type:

Article

Relationship between the Contents of Cyclins, Cyclin-Dependent Kinases, and Their Inhibitors in Whole Blood Mononuclear Leukocytes during the Postclinical Stage of Community-Acquired Pneumonia under the Influence of 1-GHz Microwaves.

Published in:

Bulletin of Experimental Biology & Medicine, 2017, v. 163, n. 5, p. 623, doi. 10.1007/s10517-017-3864-1

By:

Zilov, V.;
Khadartsev, A.;
Terekhov, I.;
Bondar', S.

Publication type:

Article

Differential expression of forkhead box M1 and its downstream cyclin-dependent kinase inhibitors p27kip1 and p21waf1/cip1 in the diagnosis of pulmonary neuroendocrine tumours.

Published in:

Histopathology, 2012, v. 60, n. 5, p. 731, doi. 10.1111/j.1365-2559.2011.04137.x

By:

Ha, Seung Yeon;
Lee, Chang Hun;
Chang, Hee Kyung;
Chang, Sunhee;
Kwon, Kun Young;
Lee, Eun Hee;
Roh, Mee Sook;
Seo, Boram

Publication type:

Article

Inflammation Resolution and the Induction of Granulocyte Apoptosis by Cyclin-Dependent Kinase Inhibitor Drugs.

Published in:

Frontiers in Pharmacology, 2019, p. N.PAG, doi. 10.3389/fphar.2019.00055

By:

Cartwright, Jennifer A.;
Lucas, Christopher D.;
Rossi, Adriano G.

Publication type:

Article

Deletion of a cyclin-dependent protein kinase inhibitor, CsSMR1, leads to dwarf and determinate growth in cucumber (Cucumis sativus L.).

Published in:

Theoretical & Applied Genetics, 2022, v. 135, n. 3, p. 915, doi. 10.1007/s00122-021-04006-7

By:

Li, Shuai;
Zhang, Qiqi;
Zhang, Huimin;
Wang, Jie;
Sun, Jinjing;
Yang, Xueyong;
Huang, Sanwen;
Zhang, Zhonghua

Publication type:

Article

Vitiligo‐like lesions induced by cyclin‐dependent kinase 4/6 inhibitor palbociclib.

Published in:

International Journal of Dermatology, 2023, v. 62, n. 2, p. e98, doi. 10.1111/ijd.16356

By:

Romagnuolo, Maurizio;
Alberti Violetti, Silvia;
Riva, Davide;
Barberi, Francesco;
Moltrasio, Chiara

Publication type:

Article